Eric Venker sold $308K of Immunovant (IMVT)

Executed Apr 2, disclosed Apr 3, 1 day later.

Value, as filed

$308K

12,820 sh × $24.04

Executed

Apr 2

the trade date, as filed

Disclosed

Apr 3

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Eric Venker President & Immunovant CEO profile →

Eric Venker (President & Immunovant CEO) filed 17 Form 4 reports in the trailing twelve months (0 purchases, 17 sales, 1 filed past the two-business-day deadline), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $7.3M of ROIV (200,000 sh × $36.62, as filed), executed Sep 30.

The name

IMVT

Immunovant, Inc. IMVT · Healthcare · 33 filings in 24 months ticker →

Healthcare · Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Eric Venker in IMVT

IMVTSALE Immunovant, Inc. $120K
3,506 sh × $34.11
Exec Oct 2
Filed Oct 5 · 7:42 PM ET IMVTSALE Immunovant, Inc. $119K
3,092 sh × $38.48
Exec Jul 2
Filed Jul 6 · 5:01 PM ET